BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8477962)

  • 1. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Poupon RE; Ouguerram K; Chrétien Y; Verneau C; Eschwège E; Magot T; Poupon R
    Hepatology; 1993 Apr; 17(4):577-82. PubMed ID: 8477962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
    Poupon RE; Chrétien Y; Poupon R; Paumgartner G
    Hepatology; 1993 Apr; 17(4):599-604. PubMed ID: 8477964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.
    Lanzarotto F; Panarotto B; Sorbara R; Panteghini M; Pagani F; Sosta S; Lanzini A
    Gut; 1999 Apr; 44(4):552-6. PubMed ID: 10075964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis.
    Balan V; Dickson ER; Jorgensen RA; Lindor KD
    Mayo Clin Proc; 1994 Oct; 69(10):923-9. PubMed ID: 7934188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.
    Oka H; Toda G; Ikeda Y; Hashimoto N; Hasumura Y; Kamimura T; Ohta Y; Tsuji T; Hattori N; Namihisa T
    Gastroenterol Jpn; 1990 Dec; 25(6):774-80. PubMed ID: 1980654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
    Güldütuna S; Leuschner M; Wunderlich N; Nickel A; Bhatti S; Hübner K; Leuschner U
    Eur J Clin Pharmacol; 1993; 45(3):221-5. PubMed ID: 8276045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
    Stojakovic T; Putz-Bankuti C; Fauler G; Scharnagl H; Wagner M; Stadlbauer V; Gurakuqi G; Stauber RE; März W; Trauner M
    Hepatology; 2007 Sep; 46(3):776-84. PubMed ID: 17668874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
    Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
    Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment.
    Batta AK; Arora R; Salen G; Tint GS; Eskreis D; Katz S
    J Lipid Res; 1989 Dec; 30(12):1953-62. PubMed ID: 2621422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
    Stiehl A; Rudolph G; Raedsch R; Möller B; Hopf U; Lotterer E; Bircher J; Fölsch U; Klaus J; Endele R
    Hepatology; 1990 Sep; 12(3 Pt 1):492-7. PubMed ID: 2401455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
    Ricci P; Hofmann AF; Hagey LR; Jorgensen RA; Rolland Dickson E; Lindor KD
    Dig Dis Sci; 1998 Jun; 43(6):1292-5. PubMed ID: 9635620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics.
    Angelin B; Nilsell K; Einarsson K
    Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
    Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
    Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids.
    Higuchi T; Hishida N; Isomura T; Takeshima H; Hayashi H
    Gastroenterol Jpn; 1992 Apr; 27(2):222-9. PubMed ID: 1577228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
    Crosignani A; Podda M; Battezzati PM; Bertolini E; Zuin M; Watson D; Setchell KD
    Hepatology; 1991 Dec; 14(6):1000-7. PubMed ID: 1959845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.